Clearmind Medicine (CMND) Total Current Liabilities (2023 - 2026)
Clearmind Medicine (CMND) posted quarterly Total Current Liabilities of $3.0 million for Q2 2026, up 3.8% year-over-year from $2.9 million in Q2 2025, and up 2.87% quarter-over-quarter from $2.9 million in Q1 2026.
Clearmind Medicine (CMND) Total Current Liabilities (2023 - 2026) Analysis & Trends
Clearmind Medicine's Total Current Liabilities history runs 4 years deep, the most recent figure standing at $3.0 million for Q2 2026.
- In Q2 2026, Total Current Liabilities rose 3.8% year-over-year to $3.0 million; the TTM figure through Apr 2026 stood at $3.0 million (up 3.8% YoY), while the FY2025 annual figure was $4.9 million, up 18.37% from the prior year.
- Total Current Liabilities for Q2 2026 stood at $3.0 million, up from $2.9 million in the prior quarter.
- The five-year high for Total Current Liabilities was $5.0 million in Q1 2024, with the low at $2.9 million in Q2 2025.
- The 4-year median for Total Current Liabilities is $4.1 million (2024), against an average of $3.9 million.
- Peak annual rise in Total Current Liabilities reached 18.37% in 2025, while the deepest fall reached 37.88% in 2025.
- Clearmind Medicine's Total Current Liabilities stood at $5.0 million in 2023, then fell by 16.87% to $4.1 million in 2024, then grew by 18.37% to $4.9 million in 2025, then sank by 38.89% to $3.0 million in 2026.
- Business Quant data shows CMND's Total Current Liabilities at $3.0 million in Q2 2026, $2.9 million in Q1 2026, and $4.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | 1.51 Bn |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | 2.49 Bn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 438.74 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 630.93 Mn |
| 10 | Clearmind Medicine | 540,485.35 | -13.05 Mn | - | 2.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 2.99 Mn |
| Jan 31, 2026 | 2.91 Mn |
| Oct 31, 2025 | 4.89 Mn |
| Jul 31, 2025 | 2.90 Mn |
| Apr 30, 2025 | 2.88 Mn |
| Jan 31, 2025 | 3.72 Mn |
| Oct 31, 2024 | 4.13 Mn |
| Jul 31, 2024 | 4.67 Mn |
| Apr 30, 2024 | 4.20 Mn |
| Jan 31, 2024 | 5.03 Mn |
| Oct 31, 2023 | 4.97 Mn |